scispace - formally typeset
D

David Lamb

Researcher at University of New England (Australia)

Publications -  404
Citations -  15273

David Lamb is an academic researcher from University of New England (Australia). The author has contributed to research in topics: Prostate cancer & Biodiversity. The author has an hindex of 56, co-authored 399 publications receiving 13856 citations. Previous affiliations of David Lamb include Charles Sturt University & University of Otago.

Papers
More filters
Journal ArticleDOI

Restoration of Degraded Tropical Forest Landscapes

TL;DR: The current scale of deforestation in tropical regions and the large areas of degraded lands now present underscore the urgent need to restore biodiversity, ecological functioning, and the supply of goods and ecological services previously used by poor rural communities.
Journal ArticleDOI

PA—Precision Agriculture: Remote-Sensing and Mapping of Weeds in Crops

TL;DR: This paper summarizes the work completed to date to investigate the use of airborne remote-sensing for weed mapping in crops, and discusses application of the technology in precision weed management practices.
Journal ArticleDOI

The Potential for Species Conservation in Tropical Secondary Forests

TL;DR: In this article, the authors considered a complex hierarchy of factors that interact in space and time to determine the conservation potential of tropical secondary forests and found that the conservation value of a secondary forest is expected to increase over time, as species arriving from remaining old-growth forest patches accumulate.
Journal ArticleDOI

Planted forests and biodiversity.

TL;DR: In this paper, the authors review the current state of knowledge on the impacts of plantation forestry on genetic and species diversity at different spatial scales and discuss the economic and ecological implications of biodiversity management within plantation stands and landscapes.
Journal ArticleDOI

Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions

TL;DR: The use of AST is associated with earlier onset of fatal MIs in men age 65 years or older who are treated for 6 months compared with men who are not treated with AST.